Trials / Completed
CompletedNCT02924337
Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects
A Randomised, Double-blind, Placebo and Active Controlled Crossover Study to Assess the Effect of Single Dose Administration of 2 Doses of Imeglimin on QT/QTc Intervals in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Poxel SA · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of a single therapeutic dose and a single supra-therapeutic dose of imeglimin on the QT/QTc interval
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Imeglimin | |
| DRUG | Moxifloxacin |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-10-05
- Last updated
- 2017-02-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02924337. Inclusion in this directory is not an endorsement.